Canada signs deals with two suppliers for potential COVID-19 vaccines
OTTAWA -- Prime Minister Justin Trudeau says the federal government has signed agreements with two more American suppliers to reserve millions of doses of their experimental COVID-19 vaccines for Canadians.
Deals are now in place for Canada to get access to vaccines being tested by both Johnson & Johnson and Novovax.
Earlier this month Ottawa signed similar deals with Pfizer and Moderna.
The vaccines are still in either Phase 2 or 3 clinical trials and won't be purchased unless they are deemed safe and effective by Health Canada.
Trudeau says the vaccines all show promising results and Canada is signing multiple deals to be sure when a vaccine is approved Canadians can get access to it.
The government says some of the doses of whatever vaccine is approved may be produced at a new biomanufacturing facility at the Human Health Therapeutics Research Centre in Montreal.
The Canadian Press
- Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines
- Canada signs deal with Novovax to get 76 million doses of COVID-19 vaccine
- Canadian-made COVID-19 vaccine approved for clinical trials by Health Canada
- Johnson & Johnson says COVID-19 vaccine 85 per cent effective against severe illness
- Health Canada to announce approval of Johnson and Johnson vaccine against COVID-19
- Male pronounced dead at scene after drowning in Brampton
- PICK A SIDE: When should masks no longer be mandatory in Ontario?
- Popular breakfast and lunch restaurant opening new location in Mississauga
- 1 in 3 Canadians considering 'workarounds' as Mississauga, Brampton and Hamilton house prices keep rising
- 16 flights landing with COVID-19 at Pearson Airport in Mississauga most since February